title: Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice.
abstract: OBJECTIVE
  To explore the potential value of myo-inositol (mIns), which is regarded as a biomarker for early diagnosis of Alzheimer's disease, in APP/PS1 transgenic (tg) mice detected by (1)H-MRS.
  
  
  METHODS
  (1)H-MRS was performed in 30 APP/PS1 tg mice and 20 wild-type (wt) littermates at 3, 5 and 8 months of age. Areas under the peak of N-acetylaspartate (NAA), mIns and creatine (Cr) in the frontal cortex and hippocampus were measured, and the NAA/Cr and mIns/Cr ratios were analyzed quantitatively.
  
  
  RESULTS
  Compared with the wt mice, the mIns/Cr ratio of the 3-month-old tg mice was significantly higher (p < 0.05), and pathology showed activation and proliferation of astrocytes in the frontal cortex and hippocampus. The concentration of NAA was significantly lower at 8 and 8 months of age (p < 0.05). According to the threshold of mIns/Cr that was adopted to separate the tg from the wt mice, the rate of correct predictions was 82, 94 and 95%, respectively, for 3, 5 and 8 months.
  
  
  CONCLUSIONS
  Of the early AD metabolites as detected by (1)H-MRS, mIns is the most valuable marker for assessment of AD. Quantitative analysis of mIns may provide important clues for early diagnosis of AD.
authors.affiliation: Department of Radiology, Tongji Hospital, Tongji University, Shanghai, China.
authors.forename: Shuang-Qing
authors.initials: SQ
authors.lastname: Chen
authors.forename: Pei-Jun
authors.initials: PJ
authors.lastname: Wang
authors.forename: Gao-Jun
authors.initials: GJ
authors.lastname: Ten
authors.forename: Wei
authors.initials: W
authors.lastname: Zhan
authors.forename: Ming-Hua
authors.initials: MH
authors.lastname: Li
authors.forename: Feng-Chao
authors.initials: FC
authors.lastname: Zang
mesh_terms: D000375:Aging / Q000502:physiology; D000544:Alzheimer Disease / Q000175:diagnosis*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics*; D015415:Biomarkers; D001923:Brain Chemistry; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism / Q000473:pathology; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007294:Inositol / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D058225:Plaque, Amyloid / Q000473:pathology; D053764:Presenilin-1 / Q000235:genetics*
chemical_list: D016229:Amyloid beta-Peptides; D001057:Apolipoproteins E; D015415:Biomarkers; D005904:Glial Fibrillary Acidic Protein; D053764:Presenilin-1; D007294:Inositol